Thomas Gayner - Markel Asset Management

Holding/activity history for  Novo Nordisk A S (NVO)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2016   Q3 1,075,000 1.15 $41.59
2016   Q2 1,075,000 1.52 $53.78
2016   Q1 1,075,000 1.56 $54.19
2015   Q4 1,075,000 1.69 $58.08
2015   Q3 1,075,000 1.54 $54.24
2015   Q2 1,075,000 1.47 $54.76
2015   Q1 1,075,000 1.45 $53.39
2014   Q4 1,075,000 1.20 $42.32
2014   Q3 1,075,000 1.44 $47.62
2014   Q2 1,075,000 1.42 $46.19
2014   Q1 1,075,000 1.51 Reduce 2.80% 0.04 $45.65
2013   Q4 1,106,000 1.29 Reduce 0.23% 0.00 $36.95
2013   Q3 1,108,500 1.29 Reduce 1.51% 0.02 $33.84
2013   Q2 1,125,500 1.25 Reduce 0.57% 0.01 $30.99
2013   Q1 1,132,000 1.36 Reduce 0.40% 0.01 $32.30
2012   Q4 1,136,500 1.55 Reduce 0.35% 0.01 $32.64
2012   Q3 1,140,500 1.54 Reduce 0.35% 0.01 $31.56
2012   Q2 1,144,500 1.52 Add 0.84% 0.01 $29.07
2012   Q1 1,135,000 1.45 Reduce 0.96% 0.01 $27.74
2011   Q4 1,146,000 1.39 Reduce 0.11% 0.00 $23.05
2011   Q3 1,147,250 1.40 $19.90
2011   Q2 1,147,250 1.53 Reduce 0.09% 0.00 $25.06
2011   Q1 1,148,250 1.56 Reduce 0.43% 0.01 $25.05
2010   Q4 1,153,250 1.45 Reduce 0.09% 0.00 $22.51
2010   Q3 1,154,250 1.37 Reduce 0.28% 0.00 $19.69
2010   Q2 1,157,500 1.28 $16.20
2010   Q1 1,157,500 1.11 Add 39.04% 0.31 $15.42
2009   Q4 832,500 0.75 Buy 0.75 $12.77